Cite
HARVARD Citation
Toth, P. et al. (n.d.). Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial. European heart journal. p. . [Online].